Was soll ich messen? Bestimmen einer zielgröße für klinische studien

Translated title of the contribution: How to determine outcomes for clinical studies

Milo A. Puhan, R. Klaghofer

Research output: Contribution to journalArticle

Abstract

Outcomes represent an essential part of clinical studies because they direct interpretation. Investigators should agree on outcomes that reflect their research question best. If the focus is on clinical aspects investigators should include patient-important outcomes. On the other hand, if mechanisms in the development or progression of diseases are of interest physiological parameters might be the better choice. Selection of outcomes may impact substantially on the study design and analysis because confounding factors could differ across different outcomes. Finally, existing literature should also be considered in order to select outcomes that were used in previous studies. Thereby, appreciation and summary of the overall evidence is facilitated.

Original languageGerman
Pages (from-to)667-671
Number of pages5
JournalTherapeutische Umschau
Volume64
Issue number12
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Research Personnel
Outcome Assessment (Health Care)
Disease Progression
Research
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Was soll ich messen? Bestimmen einer zielgröße für klinische studien. / Puhan, Milo A.; Klaghofer, R.

In: Therapeutische Umschau, Vol. 64, No. 12, 12.2007, p. 667-671.

Research output: Contribution to journalArticle

Puhan, Milo A. ; Klaghofer, R. / Was soll ich messen? Bestimmen einer zielgröße für klinische studien. In: Therapeutische Umschau. 2007 ; Vol. 64, No. 12. pp. 667-671.
@article{8f80c17eadf8453da4e082d7beee2052,
title = "Was soll ich messen? Bestimmen einer zielgr{\"o}{\ss}e f{\"u}r klinische studien",
abstract = "Outcomes represent an essential part of clinical studies because they direct interpretation. Investigators should agree on outcomes that reflect their research question best. If the focus is on clinical aspects investigators should include patient-important outcomes. On the other hand, if mechanisms in the development or progression of diseases are of interest physiological parameters might be the better choice. Selection of outcomes may impact substantially on the study design and analysis because confounding factors could differ across different outcomes. Finally, existing literature should also be considered in order to select outcomes that were used in previous studies. Thereby, appreciation and summary of the overall evidence is facilitated.",
author = "Puhan, {Milo A.} and R. Klaghofer",
year = "2007",
month = "12",
doi = "10.1024/0040-5930.64.12.667",
language = "German",
volume = "64",
pages = "667--671",
journal = "Therapeutische Umschau. Revue therapeutique",
issn = "0040-5930",
publisher = "Verlag Hans Huber",
number = "12",

}

TY - JOUR

T1 - Was soll ich messen? Bestimmen einer zielgröße für klinische studien

AU - Puhan, Milo A.

AU - Klaghofer, R.

PY - 2007/12

Y1 - 2007/12

N2 - Outcomes represent an essential part of clinical studies because they direct interpretation. Investigators should agree on outcomes that reflect their research question best. If the focus is on clinical aspects investigators should include patient-important outcomes. On the other hand, if mechanisms in the development or progression of diseases are of interest physiological parameters might be the better choice. Selection of outcomes may impact substantially on the study design and analysis because confounding factors could differ across different outcomes. Finally, existing literature should also be considered in order to select outcomes that were used in previous studies. Thereby, appreciation and summary of the overall evidence is facilitated.

AB - Outcomes represent an essential part of clinical studies because they direct interpretation. Investigators should agree on outcomes that reflect their research question best. If the focus is on clinical aspects investigators should include patient-important outcomes. On the other hand, if mechanisms in the development or progression of diseases are of interest physiological parameters might be the better choice. Selection of outcomes may impact substantially on the study design and analysis because confounding factors could differ across different outcomes. Finally, existing literature should also be considered in order to select outcomes that were used in previous studies. Thereby, appreciation and summary of the overall evidence is facilitated.

UR - http://www.scopus.com/inward/record.url?scp=38149111926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149111926&partnerID=8YFLogxK

U2 - 10.1024/0040-5930.64.12.667

DO - 10.1024/0040-5930.64.12.667

M3 - Article

C2 - 18581914

AN - SCOPUS:38149111926

VL - 64

SP - 667

EP - 671

JO - Therapeutische Umschau. Revue therapeutique

JF - Therapeutische Umschau. Revue therapeutique

SN - 0040-5930

IS - 12

ER -